Could a common sleep aid curb suicide risk? small trial aims to find out
Symptom relief
Recruiting now
This phase 2 trial tests whether suvorexant (Belsomra), a drug approved for insomnia, is safe and tolerable for veterans with major depression who are at high risk for suicide. Thirty veterans will take the drug nightly for four weeks, with in-person and remote check-ins. The stu…
Phase: PHASE2 • Sponsor: Marianne Goodman • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC